Literature DB >> 9135522

Apical effect of diosmectite on damage to the intestinal barrier induced by basal tumour necrosis factor-alpha.

L Mahraoui1, M Heyman, O Plique, M T Droy-Lefaix, J F Desjeux.   

Abstract

BACKGROUND: In many digestive diseases the intestinal barrier is weakened by the release of proinflammatory cytokines, including tumour necrosis factor-alpha (TNF alpha). AIM: To investigate the protective effect of apical diosmectite on the intestinal dysfunction induced by the proinflammatory cytokine TNF alpha.
METHODS: Filter grown monolayers of the intestinal cell line HT29-19A were incubated for 48 hours in basal medium containing 10 ng/ml TNF alpha and 5 U/ml interferon-gamma (IFN gamma). Next, 1, 10, or 100 mg/ml diosmectite was placed in the apical medium for one hour. Intestinal function was then assessed in Ussing chambers by measuring ionic conductance (G) and apicobasal fluxes of 14C-mannitol (Jman), and intact horseradish peroxidase. In control intestinal monolayers, diosmectite did not significantly modify G, Jman, or intact horseradish peroxidase.
RESULTS: After incubation with TNF alpha and IFN gamma, intestinal function altered, as shown by the increases compared with control values for G (22.8 (3.7) v (9.6 (0.5) mS/cm2), Jman (33.8 (7.5) v 7.56 (0.67) micrograms/h x cm2), and intact horseradish peroxidase (1.95 (1.12) v 0.14 (0.04) micrograms/h x cm2). G and Jman were closely correlated, suggesting that the increase in permeability was paracellular. Treatment with diosmectite restored al the variables to control values.
CONCLUSIONS: Basal TNF alpha disrupts the intestinal barrier through the tight junctions, and apical diosmectite counteracts this disruption.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9135522      PMCID: PMC1027083          DOI: 10.1136/gut.40.3.339

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  34 in total

1.  Tumour necrosis factor-alpha induces morphological and functional alterations of intestinal HT29 cl.19A cell monolayers.

Authors:  P Rodriguez; M Heyman; C Candalh; M A Blaton; C Bouchaud
Journal:  Cytokine       Date:  1995-07       Impact factor: 3.861

2.  Ultrastructural changes in the upper small intestinal mucosa in patients with cholera.

Authors:  M M Mathan; G Chandy; V I Mathan
Journal:  Gastroenterology       Date:  1995-08       Impact factor: 22.682

Review 3.  Pathophysiologic alterations induced by tumor necrosis factor.

Authors:  D G Remick; S L Kunkel
Journal:  Int Rev Exp Pathol       Date:  1993

4.  A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.

Authors:  H C Jung; L Eckmann; S K Yang; A Panja; J Fierer; E Morzycka-Wroblewska; M F Kagnoff
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

5.  Changes in gastro-intestinal motility induced by cholera toxin and experimental osmotic diarrhoea in dogs: effects of treatment with an argillaceous compound.

Authors:  J Fioramonti; M T Droy-Lefaix; L Buéno
Journal:  Digestion       Date:  1987       Impact factor: 3.216

6.  Mononuclear cells from infants allergic to cow's milk secrete tumor necrosis factor alpha, altering intestinal function.

Authors:  M Heyman; N Darmon; C Dupont; B Dugas; A Hirribaren; M A Blaton; J F Desjeux
Journal:  Gastroenterology       Date:  1994-06       Impact factor: 22.682

Review 7.  Cytokine expression in chronic inflammatory disease.

Authors:  F M Brennan; R N Maini; M Feldmann
Journal:  Br Med Bull       Date:  1995-04       Impact factor: 4.291

8.  Horseradish peroxidase transport across adult rabbit jejunum in vitro.

Authors:  M Heyman; R Ducroc; J F Desjeux; J L Morgat
Journal:  Am J Physiol       Date:  1982-06

9.  Smectite in acute diarrhea in children: a double-blind placebo-controlled clinical trial.

Authors:  A A Madkour; E M Madina; O E el-Azzouni; M A Amer; T M el-Walili; T Abbass
Journal:  J Pediatr Gastroenterol Nutr       Date:  1993-08       Impact factor: 2.839

10.  Protective action of diosmectite treatment on digestive disturbances induced by intestinal anaphylaxis in the guinea-pig.

Authors:  V Theodorou; J Fioramonti; M T Droy-Lefaix; O Plique; L Buéno
Journal:  Aliment Pharmacol Ther       Date:  1994-06       Impact factor: 8.171

View more
  16 in total

Review 1.  Measurement of novel intestinal secretory and barrier pathways and effects of proteases.

Authors:  Adam L Edwinson; Madhusudan Grover
Journal:  Neurogastroenterol Motil       Date:  2019-04       Impact factor: 3.598

2.  Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease.

Authors:  M Noguchi; N Hiwatashi; Z Liu; T Toyota
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

3.  Efficacy of the Natural Clay, Calcium Aluminosilicate Anti-Diarrheal, in Reducing Medullary Thyroid Cancer-Related Diarrhea and Its Effects on Quality of Life: A Pilot Study.

Authors:  Ramona Dadu; Mimi I Hu; Charles Cleeland; Naifa L Busaidy; Mouhammed Habra; Steven G Waguespack; Steven I Sherman; Anita Ying; Patricia Fox; Maria E Cabanillas
Journal:  Thyroid       Date:  2015-08-20       Impact factor: 6.568

4.  PAR2 activation alters colonic paracellular permeability in mice via IFN-gamma-dependent and -independent pathways.

Authors:  Nicolas Cenac; Alex C Chin; Rafael Garcia-Villar; Christel Salvador-Cartier; Laurent Ferrier; Nathalie Vergnolle; André G Buret; Jean Fioramonti; Lionel Bueno
Journal:  J Physiol       Date:  2004-06-11       Impact factor: 5.182

5.  Anti-inflammatory effect of diosmectite in hapten-induced colitis in the rat.

Authors:  Raquel González; Fermin Sánchez de Medina; Olga Martínez-Augustin; Ana Nieto; Julio Gálvez; Severiano Risco; Antonio Zarzuelo
Journal:  Br J Pharmacol       Date:  2004-03-01       Impact factor: 8.739

6.  Mitigation of colitis with NovaSil clay therapy.

Authors:  Katherine E Zychowski; Sarah E Elmore; Kristal A Rychlik; Hoai J Ly; Felipe Pierezan; Anitha Isaiah; Jan S Suchodolski; Aline Rodrigues Hoffmann; Amelia A Romoser; Timothy D Phillips
Journal:  Dig Dis Sci       Date:  2014-09-21       Impact factor: 3.199

Review 7.  Agents that act luminally to treat diarrhoea and constipation.

Authors:  Stacy Menees; Richard Saad; William D Chey
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-09-04       Impact factor: 46.802

8.  Efficacy of diosmectite (smecta) in the treatment of acute watery diarrhoea in adults: a multicentre, randomized, double-blind, placebo-controlled, parallel group study.

Authors:  Faouzi Khediri; Abdennebi Ilhem Mrad; Moussadek Azzouz; Hedi Doughi; Taoufik Najjar; Hélène Mathiex-Fortunet; Philippe Garnier; Antoine Cortot
Journal:  Gastroenterol Res Pract       Date:  2011-06-30       Impact factor: 2.260

9.  Role of antidiarrhoeal drugs as adjunctive therapies for acute diarrhoea in children.

Authors:  Christophe Faure
Journal:  Int J Pediatr       Date:  2013-03-03

10.  Lactobacillus GG (LGG) and smectite versus LGG alone for acute gastroenteritis: a double-blind, randomized controlled trial.

Authors:  Małgorzata Pieścik-Lech; Magdalena Urbańska; Hania Szajewska
Journal:  Eur J Pediatr       Date:  2012-11-01       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.